•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 

A09078 Summary:

BILL NOA09078B
 
SAME ASSAME AS S06346-B
 
SPONSORMayer
 
COSPNSRSkoufis, Lupardo, Otis, Simon, Zebrowski, Cusick, Jaffee, Galef, Duprey, Ra, Peoples-Stokes, Brabenec, Finch, Abinanti
 
MLTSPNSRTenney, Thiele
 
Amd §3309, Pub Health L
 
Requires any chain pharmacy with twenty or more locations to pursue or maintain a non-patient specific prescription with an authorized health care professional to disperse an opioid antagonist to a consumer upon request, or to register with the department of health as an opioid overdose prevention program.
Go to top

A09078 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A9078B        REVISED MEMO 06/08/2016
 
SPONSOR: Mayer
  TITLE OF BILL: An act to amend the public health law, in relation to requiring any chain pharmacy with twenty or more locations to pursue or maintain a non-patient-specific prescription with an authorized health care professional to dispense an opioid antagonist to a consumer upon request, or to register with the department of health as an opioid over- dose prevention program   PURPOSE OR GENERAL IDEA OF BILL: The purpose of this legislation is to ensure access to life saving medi- cation to reverse the effects of heroin and opioid overdoses at pharma- cies across the state without a prescription.   SUMMARY OF SPECIFIC PROVISIONS: Section 1 amends paragraph b of subdivision 3 of section 3309 of the public health law by adding a new subparagraph v to require any pharmacy with twenty or more locations in the state to either pursue or maintain a non-patient specific prescription with an authorized health care professional to dispense an opioid antagonist, or register with the department of health as an opioid overdose prevention program. Section 2 establishes the effective date.   JUSTIFICATION: Heroin and opioid abuse is an alarming problem that affects communities small and large across New York State, and across the nation. In 2014, there were 121,000 admissions for heroin and prescription opioid abuse treatment in New York State, a 20 percent increase from 101,000 in 2009. Since 2002, deaths stemming from Heroin-related overdoses have quadru- pled and continue to rise. New York State has already taken several steps to combat this epidemic which plagues our communities. However, New York has lagged behind other states when it comes to ensuring access to Naloxone, the lifesaving medication used to reverse the effects of opioids during an overdose. When administered, naloxone can temporarily block the effects of the opioid, whether illicit or prescription, allow- ing the individual to regain consciousness and resume normal breathing. It poses no danger to anyone who otherwise might come into contact with it. A number of other states have already taken steps to expand access to Naloxone by issuing a standing order to allow this life saving medi- cation to be dispensed at pharmacies without a prescription. Studies have shown that friends and family members of overdose victims are often the actual first responders and are typically better able to intervene within the critical first moments of the onset of an overdose. By requiring certain pharmacies to dispense and administer Naloxone without a prescription, whether through pursuing or maintaining a non-patient specific prescription with an authorized health care professional or through registering as an opioid overdose prevention program, we can facilitate the distribution of this medication and help save lives.   PRIOR LEGISLATIVE HISTORY: New bill.   FISCAL IMPLICATIONS: None.   EFFECTIVE DATE: Immediately.
Go to top

A09078 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         9078--B
                                                                Cal. No. 610
 
                   IN ASSEMBLY
 
                                    January 25, 2016
                                       ___________
 
        Introduced  by M. of A. MAYER, SKOUFIS, LUPARDO, OTIS, SIMON, ZEBROWSKI,
          CUSICK, JAFFEE, GALEF, DUPREY, RA,  PEOPLES-STOKES,  BRABENEC,  FINCH,
          ABINANTI -- Multi-Sponsored by -- M. of A. TENNEY, THIELE -- read once
          and  referred  to  the Committee on Health -- reported from committee,
          advanced to a third reading, amended and ordered reprinted,  retaining
          its  place  on  the  order  of third reading -- again amended on third
          reading, ordered reprinted, retaining its place on the order of  third
          reading
 
        AN  ACT  to  amend  the  public health law, in relation to requiring any
          chain pharmacy with twenty or more locations to pursue or  maintain  a
          non-patient-specific  prescription  with  an  authorized  health  care
          professional to dispense an  opioid  antagonist  to  a  consumer  upon
          request,  or  to  register  with the department of health as an opioid
          overdose prevention program
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Paragraph  (b)  of  subdivision  3 of section 3309 of the
     2  public health law is amended by adding a new subparagraph (v) to read as
     3  follows:
     4    (v) Any pharmacy with twenty or more locations  in  the  state,  shall
     5  either:  (1) pursue or maintain a non-patient-specific prescription with
     6  an authorized health care professional to dispense an opioid  antagonist
     7  to a consumer upon request, as authorized by this section; or (2) regis-
     8  ter with the department as an opioid overdose prevention program.
     9    § 2. This act shall take effect immediately.
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13480-07-6
Go to top